243 related articles for article (PubMed ID: 33543029)
1. Serglycin activates pro-tumorigenic signaling and controls glioblastoma cell stemness, differentiation and invasive potential.
Manou D; Bouris P; Kletsas D; Götte M; Greve B; Moustakas A; Karamanos NK; Theocharis AD
Matrix Biol Plus; 2020 May; 6-7():100033. PubMed ID: 33543029
[TBL] [Abstract][Full Text] [Related]
2. Serglycin promotes breast cancer cell aggressiveness: Induction of epithelial to mesenchymal transition, proteolytic activity and IL-8 signaling.
Bouris P; Manou D; Sopaki-Valalaki A; Kolokotroni A; Moustakas A; Kapoor A; Iozzo RV; Karamanos NK; Theocharis AD
Matrix Biol; 2018 Dec; 74():35-51. PubMed ID: 29842969
[TBL] [Abstract][Full Text] [Related]
3. Tumorigenic functions of serglycin: Regulatory roles in epithelial to mesenchymal transition and oncogenic signaling.
Manou D; Karamanos NK; Theocharis AD
Semin Cancer Biol; 2020 May; 62():108-115. PubMed ID: 31279836
[TBL] [Abstract][Full Text] [Related]
4. Modulation of phorbol ester-induced regulation of matrix metalloproteinases and tissue inhibitors of metalloproteinases by SB203580, a specific inhibitor of p38 mitogen-activated protein kinase.
Park MJ; Park IC; Hur JH; Kim MS; Lee HC; Woo SH; Lee KH; Rhee CH; Hong SI; Lee SH
J Neurosurg; 2002 Jul; 97(1):112-8. PubMed ID: 12134900
[TBL] [Abstract][Full Text] [Related]
5. Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor.
Nicholl SM; Roztocil E; Davies MG
J Vasc Surg; 2005 Apr; 41(4):672-81. PubMed ID: 15874933
[TBL] [Abstract][Full Text] [Related]
6. Modulation of uPA, MMPs and their inhibitors by a novel nutrient mixture in human glioblastoma cell lines.
Roomi MW; Kalinovsky T; Niedzwiecki A; Rath M
Int J Oncol; 2014 Aug; 45(2):887-94. PubMed ID: 24867464
[TBL] [Abstract][Full Text] [Related]
7. Serglycin as a potential biomarker for glioma: association of serglycin expression, extent of mast cell recruitment and glioblastoma progression.
Roy A; Attarha S; Weishaupt H; Edqvist PH; Swartling FJ; Bergqvist M; Siebzehnrubl FA; Smits A; Pontén F; Tchougounova E
Oncotarget; 2017 Apr; 8(15):24815-24827. PubMed ID: 28445977
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor receptor-mediated regulation of urokinase plasminogen activator expression and glioblastoma invasion via C-SRC/MAPK/AP-1 signaling pathways.
Amos S; Redpath GT; Dipierro CG; Carpenter JE; Hussaini IM
J Neuropathol Exp Neurol; 2010 Jun; 69(6):582-92. PubMed ID: 20467333
[TBL] [Abstract][Full Text] [Related]
9. Extracellular serglycin upregulates the CD44 receptor in an autocrine manner to maintain self-renewal in nasopharyngeal carcinoma cells by reciprocally activating the MAPK/β-catenin axis.
Chu Q; Huang H; Huang T; Cao L; Peng L; Shi S; Zheng L; Xu L; Zhang S; Huang J; Li X; Qian C; Huang B
Cell Death Dis; 2016 Nov; 7(11):e2456. PubMed ID: 27809309
[TBL] [Abstract][Full Text] [Related]
10. IL-6 and soluble IL-6 receptor stimulate the production of MMPs and their inhibitors via JAK-STAT and ERK-MAPK signalling in human chondrocytes.
Aida Y; Honda K; Tanigawa S; Nakayama G; Matsumura H; Suzuki N; Shimizu O; Takeichi O; Makimura M; Maeno M
Cell Biol Int; 2012 Apr; 36(4):367-76. PubMed ID: 22087578
[TBL] [Abstract][Full Text] [Related]
11. Significance of serglycin and its binding partners in autocrine promotion of metastasis in esophageal cancer.
Zhu Y; Lam AKY; Shum DKY; Cui D; Zhang J; Yan DD; Li B; Xu WW; Lee NPY; Chan KT; Law S; Tsao SW; Cheung ALM
Theranostics; 2021; 11(6):2722-2741. PubMed ID: 33456569
[No Abstract] [Full Text] [Related]
12. Sphingosine-1-phosphate and interleukin-1 independently regulate plasminogen activator inhibitor-1 and urokinase-type plasminogen activator receptor expression in glioblastoma cells: implications for invasiveness.
Bryan L; Paugh BS; Kapitonov D; Wilczynska KM; Alvarez SM; Singh SK; Milstien S; Spiegel S; Kordula T
Mol Cancer Res; 2008 Sep; 6(9):1469-77. PubMed ID: 18819934
[TBL] [Abstract][Full Text] [Related]
13. Osteopontin induces AP-1-mediated secretion of urokinase-type plasminogen activator through c-Src-dependent epidermal growth factor receptor transactivation in breast cancer cells.
Das R; Mahabeleshwar GH; Kundu GC
J Biol Chem; 2004 Mar; 279(12):11051-64. PubMed ID: 14704150
[TBL] [Abstract][Full Text] [Related]
14. Serglycin Is Involved in TGF-β Induced Epithelial-Mesenchymal Transition and Is Highly Expressed by Immune Cells in Breast Cancer Tissue.
Tellez-Gabriel M; Tekpli X; Reine TM; Hegge B; Nielsen SR; Chen M; Moi L; Normann LS; Busund LR; Calin GA; Mælandsmo GM; Perander M; Theocharis AD; Kolset SO; Knutsen E
Front Oncol; 2022; 12():868868. PubMed ID: 35494005
[TBL] [Abstract][Full Text] [Related]
15. Serglycin is a major proteoglycan in polarized human endothelial cells and is implicated in the secretion of the chemokine GROalpha/CXCL1.
Meen AJ; Øynebråten I; Reine TM; Duelli A; Svennevig K; Pejler G; Jenssen T; Kolset SO
J Biol Chem; 2011 Jan; 286(4):2636-47. PubMed ID: 21075844
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of uPA inhibits migration and PI3k/Akt signaling in glioblastoma cells.
Chandrasekar N; Mohanam S; Gujrati M; Olivero WC; Dinh DH; Rao JS
Oncogene; 2003 Jan; 22(3):392-400. PubMed ID: 12545160
[TBL] [Abstract][Full Text] [Related]
17. Osteopontin: it's role in regulation of cell motility and nuclear factor kappa B-mediated urokinase type plasminogen activator expression.
Das R; Philip S; Mahabeleshwar GH; Bulbule A; Kundu GC
IUBMB Life; 2005 Jun; 57(6):441-7. PubMed ID: 16012053
[TBL] [Abstract][Full Text] [Related]
18. Mammalian target of rapamycin inhibitors, temsirolimus and torin 1, attenuate stemness-associated properties and expression of mesenchymal markers promoted by phorbol-myristate-acetate and oncostatin-M in glioblastoma cells.
Chandrika G; Natesh K; Ranade D; Chugh A; Shastry P
Tumour Biol; 2017 Mar; 39(3):1010428317695921. PubMed ID: 28351321
[TBL] [Abstract][Full Text] [Related]
19. Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells.
Wang F; Li H; Yan XG; Zhou ZW; Yi ZG; He ZX; Pan ST; Yang YX; Wang ZZ; Zhang X; Yang T; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():575-601. PubMed ID: 25632225
[TBL] [Abstract][Full Text] [Related]
20. Serglycin secretion is part of the inflammatory response in activated primary human endothelial cells in vitro.
Reine TM; Vuong TT; Jenssen TG; Kolset SO
Biochim Biophys Acta; 2014 Aug; 1840(8):2498-505. PubMed ID: 24513305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]